The Venture Codex Logo

The Venture Codex

Overview

AAV gene therapy company developing affordable rAAV therapies.

Total Raised

$160 M

Rounds

1

Links

Verticals

Biotechnology

Investment History

  1. Series B

    Jul 2022

    $160M

Team

Xinyan Li

Co-Founder and CEO

Dean Falb

Chief Scientific Officer

Dianne M Brennick

Senior Human Resources Manager

Robert Lu

VP of Technical Operations